3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
5
Lymphoma, Mantle-Cell
4
Lymphoma, B-Cell
3
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Lymphoma
2
Waldenstrom Macroglobulinemia
1
Recurrence
1
Neoplasms
1
Mature B-Cell Malignancies
1
Hematologic Diseases
1
Interventions
Cyclophosphamide
6
fludarabine
4
Standard of Care
4
Practice Guidelines as Topic
3
Mycophenolic Acid
3
GSK2636771
3
venetoclax
2
trametinib
2
talquetamab
2
osimertinib
2
dabrafenib
2
X-Rays
2
Whole-Body Irradiation
2
Thiotepa
2
Tacrolimus
2
Specimen Handling
2
Mesna
2
Melphalan
2
Magnetic Resonance Spectroscopy
2
Filgrastim
2
Biopsy
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
thymoglobulin
1
sapanisertib
1
ruxolitinib
1
relatlimab
1
plerixafor
1
pertuzumab
1
pembrolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hematologic Neoplasms
×
zanubrutinib
×
30 days
×
Clear all
No trials found.